Camlin Fine Sciences Limited · NSE:CAMLINFINE
Camlin Fine Sciences — Q3 FY2023 Earnings Presentation
39 slides from Camlin Fine Sciences's earnings presentation, Feb 13, 2023
Slide 1: Stock exchange intimation letter
February 13, 2023 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai‐ 400051 Ref: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation
Slide 2: Camlin Fine Sciences Ltd. Investor Presentation – February 2023
Camlin Fine Sciences Ltd. Investor Presentation – February 2023
Slide 3: Safe Harbour
Safe Harbour 5 This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for a
Slide 4: Q3 & 9M FY23 Highlights
Q3 &9M FY23 Highlights #start your story
Slide 5: Q3 FY23 Operational Highlights
Q3 FY23 Operational Highlights 5 Revenue Rs. 3,878 Mn EBITDA Rs. 498 Mn PAT Rs. 229 Mn 12.8% 5.9% Margin Operational Updates › Operating revenue were lower due to general slowdown in the global economies and de-stocking in the quarter in global distribution and consumption channels. › Quarter on Qua
Slide 6: Quarterly Highlights and Nine Months Highlights
Performance Highlights 5 Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 14.5% 11.4% 12.8% 7.1% 2.0% 5.9% Margin +2% Quarterly Highlights 4,832 -10% -16% 3,808 3,878 552 552 272 498 229 99 Q3FY22 Q2FY23 Q3FY23 Q3FY22 Q2FY23 Q3FY23 Q3 FY22 Q2 FY23 Q3 FY23 12.6% 12.4% 4.6% 2.9% Nine Months High
Slide 7: Operational Revenue Break-up
Operational Revenue Break-up 5 Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) +27% +23% +25% 3,519 3,812 7,330 2,766 3,094 5,860 -3% +6% +1% 1,192 1,156 1,208 1,274 2,400 2,430 Q3 FY22 Q3 FY23 9M FY22 9M FY23 Q3 FY22 Q3FY23 9M FY22 9MFY23 Q3FY22 Q3FY23 9MFY
Slide 8: Regional Highlights
Regional Highlights 5 CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) +18% +11% +27% 5,713 2,684 3,868 4,841 2,426 3,051 -14% -3% +14% 2,002 1,727 913 884 874 993 Q3FY22 Q3FY23 9MFY22 9MFY23 Q3FY22 Q3FY23 9MFY22 9MFY23 Q3FY22 Q3FY23 9MFY22 9MFY23 CFS Brazil (Rs. In Mn) CFS North
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement 5 Particulars (Rs. In Mn) Q3FY23 Q3FY22 YoY 9MFY23 9MFY22 YoY Revenue from Operation 3,878.4 3,808.2 1.8% 12,548.6 10,228.6 22.7% Raw material consumption 1,856.5 2,028.2 6,022.4 5,567.3 Employee Cost 417.1 399.9 1,217.9 1,072.9 Other expenses 1,107.2 828.4 3,755
Slide 10: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement 5 Particulars (Rs. In Mn) Q3FY23 Q3FY22 YoY 9MFY23 9MFY22 YoY Revenue from Operation 1,726.9 2,002.2 -13.8% 5,712.8 4,841.2 18.0% Raw material consumption 714.2 1,189.0 2,682.3 2,899.2 Employee Cost 162.4 152.8 432.0 396.9 Other expenses 575.1 429.1 1,737.2 1,083.1
Slide 11: Bringing Science to Everyday Life
B r i n g i n g S c i e n c e t o E ve r y d ay L i fe #start your story
Slide 12: Company Overview
Company Overview 5 Camlin Fine Sciences Ltd. is a vertically integrated company, engaged in the research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. 2006 Leading Preferred manufacturer of Partner for Established Antioxidants Customised Products Rs 1
Slide 13: Business Verticals & Industries Served
Business Verticals & Industries Served 5 Business Mix 9M FY23* <1% <1% 40% 59% Sales Mix › Functional Foods › Pharma Intermediates › Food End User Industries › Feed & Food › Personal Care & Home Care › Livestock Feed › Petrochemicals › Animal Nutrition › Flavours & Fragrances › Dietary Supplements ›
Slide 14: Strategically Located
Strategically Located 5 80+ Countries USA Italy China Presence Mexico Cuba India Dominican Gautemala Republic Colombia Singapore 1,000+ Customers Peru Brazil Chille Argentina CFS Wanglong CFS North CFS Dresen (Dresen Camlin Fine Sciences & ` CFS do Brasil Ltda. CFS Europe SpA Flavours (Ningbo), Amer
Slide 15: Global Research & Development
Global Research & Development 5 Application Labs › Develops customized blends for various applications › Provides technical assistance and development support to customers • Mexico City › Tests of defined performance parameters • Des Moines, USA › Conducts stability studies for various products of s
Slide 16: Over The Decades, A Prestigious Brand Has Emerged
Over The Decades,A Prestigious Brand Has Emerged 5 FY94 FY07 FY12 FY14 › Camlin Fine Chemical division › Camlin Fine Sciences Ltd. was › Acquired Borregaard Italia › Introduced extensive range of incorporated in Camlin Ltd. to formed after de-merging SpA, a manufacturing facility in performance chem
Slide 17: Complex Chemistry With High Barriers
Complex Chemistry With High Barriers 5 Long Gestation Period High Replacement Cost Tight Regulations Customer acquisition takes a long Our global presence, growing scale, Complying with a wide range of laws, time, thus there are only a few reliable supply chain, rationalized cost regulations and pra
Slide 18: Key Strengths
Key Strengths 5 1 Leading, global player in shelf-life solutions across food, feed, pet-food and Biodiesel 2 Local presence in major global markets 3 Advanced R&D facilities & Application Labs 4 Proven ability to acquire and improve business performance 5 Vertically integrated across the value chain
Slide 19: Business Overview
Business Overview #start your story
Slide 20: Shelf Life Solutions
Shelf Life Solutions 5 End User Industries Total Operational Revenue (Rs. in Mn) Product portfolio 7,980 7,330 Foods 6,171 Antioxidants (straights) Blends & Other Additives 5,516 3,812 4,856 3,519 2,860 Established player in the global market with over 2,381 Pet Food 2,248 30 years of experience 4,1
Slide 21: Performance Chemicals
Performance Chemicals 5 End User Industries › Performance Chemicals are specialty chemicals sold on the basis of their Total Operational Revenue (Rs. in Mn) performance for specific industrial applications › Entered into a long-term preferred supply agreement with Lockheed Martin Advanced Energy Sto
Slide 22: Aroma Ingredients
Aroma Ingredients 5 End User Industries › CFS produces Vanillin through the Catechol route and its brand is one of the Total Operational Revenue (Rs. in Mn) most trusted by the Food and Flavours Industry. › Vanillin is a synthetic substitute to natural vanilla derived from vanilla beans, which is ve
Slide 23: Health & Wellness
Health & Wellness 5 End User Industries › Launched in 2019 to cater to the rising awareness and growing demand for natural products. › Offers nutraceutical products derived by plant extraction and fermentation such as natural colours, Pet Food functional ingredients, plant-based extracts in natural
Slide 24: CFS 2.0
CFS 2.0 #start your story
Slide 25: CFS 2.0
CFS 2.0 5 CFS CFS 1.0 2.0 Further Improving Advancing Expansion in Preparing Operational Growth Acceleration Downstream For Future Efficiencies Strategies Products 24
Slide 26: Manufactured In-house
Integration Chain 5 Phenol Manufactured In-house Hydroquinone Diphenols Catechol Performance Performance Shelf Life Solutions Chemicals Aroma Ingredients Chemicals Ascorbyl Palmitate1 TBHQ MEHQ Guaiacol Guethol BHA Other derivatives of HQ Veratrole Vanillin Other derivatives of Blends Catechol Ethyl
Slide 27: Improving Operational Efficiencies
Improving Operational Efficiencies 5 Key Rational Before Dahej Expansion: After Dahej Expansion: › Backward Integrated through Italy & Dahej Facility › Diphenols were manufactured in Italy and › Diphenol captive requirement in India will be met › Became one of the leading low cost transported to man
Slide 28: Well Placed to Expand Downstream Products
Well Placed to Expand Downstream Products 5 Wide Product Basket Key Products Our Presence Hydroquinone Catechol › High Volatile Business › High Volatile Business › Supply Deficit in Global Market › Oversupply in Global Market MEHQ ✓ › High Demand › Moderate Demand BHA ✓ Guaiacol ✓ Ascorbyl Palmitate
Slide 29: Advancing Our Growth Strategy
Advancing Our Growth Strategy 5 › With a diverse product portfolio, worldwide presence, › 15,000 MT greenfield facility at Dahej, Gujarat strengthens the CFS continuous focus on R&D, and healthy financial position, capabilities in Diphenols CFS is well-positioned to benefit from sectoral Dahej Facil
Slide 30: Preparing For Future Growth
Preparing For Future Growth 5 Building Additional Multipurpose Plant › Commenced 6,000 MT Vanillin facility at Dahej, Gujarat to make Vanillin & Ethyl Vanillin › The low-cost Catechol obtained from the latest Dahej facility will improve EBITDA margins, giving CFS a significant competitive edge & Pro
Slide 31: Way Forward: Acceleration
Way Forward : Acceleration 5 Acceleration SHELF-LIFE SOLUTIONS AROMA INGREDIENTS › Increasing focus on high margin blends and › Commenced 6,000 MT Vanillin facility at Dahej additives › Focusing on cost efficient manufacturing of Vanillin › Introducing new products, cross-selling leading to improved
Slide 32: ESG Highlights
ESG Highlights 5 › Carefully chosen product portfolio to provide environmental benefits addressing large societal challenges like food waste prevention. Environment › CFS is proactively working towards sourcing clean energy from wind energy farm with a capacity of 1.25MW which could replace upto 20%
Slide 33: Key Clients and Certificates
Key Clients and Certificates 5 Key Clients Key Certificates The Brand Names and Logos mentioned are the property of their respective owners and are used here for identification purposes only 32
Slide 34: Board of Directors
Board of Directors 5 Ashish Dandekar Nirmal Momaya Arjun Dukane Harsha Raghavan Chairman & Managing Director Managing Director Executive Director - Technical Non Executive Non-Independent • BA in Economics and Management studies form • CA with over 25 years of experience in Finance, Taxation, • Chem
Slide 35: Financial Highlights
Financial Highlights #start your story
Slide 36: Operational Revenue Break-Up
Operational Revenue Break-Up 5 Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) 3,812 4,168 7,980 3,519 3,812 7,330 2,860 3,135 3,311 6,171 5,516 2,248 2,381 2,608 4,856 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21 FY22 9MFY23 Performa
Slide 37: Regional Highlights
Regional Highlights 5 CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 6,855 3,198 4,395 5,798 6,000 5,713 2,735 2,684 3,762 3,868 5,481 2,571 3,296 3,091 2,172 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21 FY22 9MFY23 CFS Brazil (Rs. In Mn) CFS Wanglong (Rs
Slide 38: Historical Financial Highlights
Historical Financial Highlights 5 Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 7.7% 12.5% 15.3% 10.8% 12.4% 0.3% 2.8% 5.5% 4.3% 2.9% Margin 14,121 12,549 1,819 654 11,871 604 10,491 1,528 1,553 8,922 1,307 363 298 687 30 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21 FY22 9MFY23 FY19 FY20 FY21
Slide 39: Thank You
Thank You Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Mr. Santosh Parab- CFO Email – [email protected] www.camlinfs.com #start your story Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Jigar Kavaiya / Mr. Shrikant Sangani Email – [email protected] / shri
Camlin Fine Sciences — Q3 FY2023 Earnings Presentation on 6ix